JNC V revisited: Standard of care or individualized treatment for hypertension?

American Heart Journal

Volumn 135, Issue 2 II, 1998, Pages

  Alderman, M H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; CORONARY RISK; HUMAN; HYPERTENSION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0031937440     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-8703(98)70308-4     Document Type: Review

References (31)

1. S MacMahon R Peto J Cutler R Collins P Sorlie J Neaton Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias Lancet 335 1990 765 774
2. WB. Kannel Hypertension and the risk of cardiovascular disease JH Laragh BM Brenner Hypertension: pathophysiology, diagnosis, and management. 1990 Raven Press New York 101 117
3. R Collins R Peto S MacMahon P Hebert NH Fiebach KA Eberlein Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context Lancet 335 1990 827 838
4. J Stamler G Rose R Stamler P Elliott A Dyer M. Marmot INTERSALT study findings: public health and medical care implications Hypertension 14 1989 570 577
5. American Heart Association 1997 heart and stroke statistical update 1996 American Heart Association Dallas
6. National High Blood Pressure Education Program National high blood pressure education program working group report on hypertension and chronic renal failure Arch Intern Med 151 1991 1280 1287
7. MGM Hunink L Goldman ANA Tosteson MA Mittleman PA Goldman LW Williams The recent decline in mortality from coronary heart disease, 1980-1990 JAMA 277 1997 535 542
8. JK Ghali R Cooper E. Ford Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence Arch Intern Med 150 1990 769 773
9. MJ Horan Implications for research and policy in the treatment of hypertension: medical considerations Hypertension 13 suppl I 1989 I-164 I-166
10. Veterans Administration Cooperative Study Group on Antihypertensive Agents Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg JAMA 213 1970 1143 1152
11. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) Arch Intern Med 153 1993 154 183
12. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension JAMA 265 1991 3255 3264
13. BM Psaty SR Heckbert TD Koepsell DS Siscovick TE Raghunathan NS Weiss The risk of myocardial infarction associated with antihypertensive drug therapies JAMA 274 1995 620 625
14. M Pahor JM Guralnik M-C Corti DJ Foley P Carbonin RJ Havlik Long-term survival and use of antihypertensive medications in older persons J Am Geriatr Soc 43 1995 1191 1197
15. CD Furberg BM Psaty JV. Meyer Nifedipine. Dose-related increase in mortality in patients with coronary heart disease Circulation 92 1995 1326 1331
16. J Staesson A Amery W Birkenhäger Syst-Eur—a multicenter trial on the treatment of isolated systolic hypertension in the elderly: first interim report J Cardiovasc Pharmacol 19 1992 120 125
17. S Suraniti G Berrut M Marre P Fressinaud Antihypertensive efficacy and acceptability of perindopril in elderly hypertensive patients Am J Cardiol 71 1993 28E 31E
18. JR Rosenthal U Osowski Tolerability and efficacy of antihypertensive treatment with cilazapril in general practice Cardiology 87 1996 54 59
19. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
20. C Borghi E Ambrosioni B Magnani on behalf of the SMILE Study Investigators Effects of the early administration of zofenopril on onset and progression of congestive heart failure in patients with anterior wall acute myocardial infarction Am J Cardiol 78 1996 317 322
21. G Maschio D Alberti G Janin F Locatelli JFE Mann M Motolese the Angiotensin-Converting–Enzyme Inhibition in Progressive Renal Insufficiency Study Group Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency N Engl J Med 334 1996 939 945
22. MH Alderman Absolute cardiovascular risk: the basis for deciding to treat Am J Nephrol 16 1996 182 189
23. S Madhavan MH Alderman The potential effect of blood pressure reduction on cardiovascular disease: a cautionary note Arch Intern Med 141 1981 1583 1586
24. J Ménard G Chatellier Mild hypertension: the mysterious viability of a faulty concept J Hypertens 13 1995 1071 1077
25. R Jackson P Barham J Bills T Birch L McLennan S MacMahon Management of raised blood pressure in New Zealand: a discussion document BMJ 307 1993 107 110
26. MH Alderman S Madhavan WL Ooi H Cohen JE Sealey JH Laragh Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension N Engl J Med 324 1991 1098 1104
27. WB Kannel DK McGee T Gordon A general cardiovascular risk profile: the Framingham study Am J Cardiol 38 1976 46 51
28. MH Alderman S Madhavan J. Fang Prognostic stratification among hypertensive patients prior to long-term therapy. Abstract sent to Eighth European Meeting on Hypertension, European Society of Hypertension 13-16 June 1997 Milan, Italy
29. MH Alderman S Madhavan H Cohen Changing patterns of cardiovascular disease events during 20 years of antihypertensive therapy [abstract] Hypertension 28 1996 510
30. LR Krakoff American Society of Hypertension workshop on absolute risk Am J Hypertens 9 1996 397 399
31. DJ Malenka JA Baron S Johansen JW Wahrenberger JM Ross The framing effect of relative and absolute risk J Gen Intern Med 8 1993 543 548